Brad A. Palanski

1.3k total citations
15 papers, 261 citations indexed

About

Brad A. Palanski is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Brad A. Palanski has authored 15 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Cell Biology. Recurrent topics in Brad A. Palanski's work include Blood properties and coagulation (5 papers), Celiac Disease Research and Management (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Brad A. Palanski is often cited by papers focused on Blood properties and coagulation (5 papers), Celiac Disease Research and Management (4 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Brad A. Palanski collaborates with scholars based in United States, Spain and Germany. Brad A. Palanski's co-authors include Chaitan Khosla, Megan A. Albertelli, Philip A. Cole, Arti V. Shinde, Nikolaos G. Frangogiannis, Ya Su, Mario J. García, Kana Fujikura, Beatriz del Río and Holden T. Maecker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Brad A. Palanski

14 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brad A. Palanski United States 10 116 64 49 37 37 15 261
Martin Hils Germany 12 68 0.6× 159 2.5× 128 2.6× 38 1.0× 67 1.8× 18 388
Kun Zhuang China 13 262 2.3× 46 0.7× 29 0.6× 106 2.9× 44 1.2× 28 425
Junyan Qu China 10 92 0.8× 119 1.9× 42 0.9× 112 3.0× 64 1.7× 19 331
Tianlian Yan China 10 156 1.3× 60 0.9× 32 0.7× 122 3.3× 82 2.2× 14 350
Chunyan Song China 11 173 1.5× 44 0.7× 23 0.5× 168 4.5× 46 1.2× 17 481
Dong-zhu Zeng China 11 161 1.4× 171 2.7× 122 2.5× 111 3.0× 59 1.6× 22 480
Midori Suzuki Japan 12 181 1.6× 17 0.3× 23 0.5× 38 1.0× 44 1.2× 31 350
Ling Lv China 11 168 1.4× 57 0.9× 20 0.4× 54 1.5× 10 0.3× 19 318
Masatake Iida Japan 10 176 1.5× 31 0.5× 36 0.7× 84 2.3× 25 0.7× 18 562
Kyra Minahan Australia 9 161 1.4× 38 0.6× 7 0.1× 27 0.7× 25 0.7× 11 322

Countries citing papers authored by Brad A. Palanski

Since Specialization
Citations

This map shows the geographic impact of Brad A. Palanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad A. Palanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad A. Palanski more than expected).

Fields of papers citing papers by Brad A. Palanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad A. Palanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad A. Palanski. The network helps show where Brad A. Palanski may publish in the future.

Co-authorship network of co-authors of Brad A. Palanski

This figure shows the co-authorship network connecting the top 25 collaborators of Brad A. Palanski. A scholar is included among the top collaborators of Brad A. Palanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad A. Palanski. Brad A. Palanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
McCool, Ryan S., Abigail E. Powell, Daniel J Stieh, et al.. (2026). Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen. Nature Communications. 17(1). 1197–1197. 1 indexed citations
2.
O’Meara, Timothy R., et al.. (2025). Mutant protein chemical rescue: From mechanisms to therapeutics. Journal of Biological Chemistry. 301(4). 108417–108417.
3.
Dempsey, Daniel R., et al.. (2023). Semisynthetic Approach to the Analysis of Tumor Suppressor PTEN Ubiquitination. Journal of the American Chemical Society. 145(11). 6039–6044. 6 indexed citations
4.
Nardone, Christopher, Brad A. Palanski, Daniel C. Scott, et al.. (2023). A central role for regulated protein stability in the control of TFE3 and MITF by nutrients. Molecular Cell. 83(1). 57–73.e9. 29 indexed citations
5.
Palanski, Brad A., Lichao Zhang, Andrew J. Hilmer, et al.. (2022). An efficient urine peptidomics workflow identifies chemically defined dietary gluten peptides from patients with celiac disease. Nature Communications. 13(1). 888–888. 29 indexed citations
6.
Balana, Aaron T., Nam Chu, Hanjie Jiang, et al.. (2021). Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications. ACS Chemical Biology. 17(1). 68–76. 12 indexed citations
7.
Dempsey, Daniel R., Thibault Viennet, Eunyoung Park, et al.. (2021). The structural basis of PTEN regulation by multi-site phosphorylation. Nature Structural & Molecular Biology. 28(10). 858–868. 27 indexed citations
8.
Sankaranarayanan, Karthik, Brad A. Palanski, Camilla M. Kao, et al.. (2019). Tunable Enzymatic Synthesis of the Immunomodulator Lipid IVA To Enable Structure–Activity Analysis. Journal of the American Chemical Society. 141(24). 9474–9478. 5 indexed citations
9.
Palanski, Brad A., et al.. (2019). In Vivo Measurement of Redox-Regulated TG2 Activity. Methods in molecular biology. 1967. 263–274. 4 indexed citations
10.
Palanski, Brad A. & Chaitan Khosla. (2018). Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism. Biochemistry. 57(24). 3359–3363. 28 indexed citations
11.
Shinde, Arti V., Ya Su, Brad A. Palanski, et al.. (2018). Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload. Journal of Molecular and Cellular Cardiology. 117. 36–48. 27 indexed citations
12.
Zhao, Qinglan, et al.. (2018). Interleukin 4 is inactivated via selective disulfide-bond reduction by extracellular thioredoxin. Proceedings of the National Academy of Sciences. 115(35). 8781–8786. 23 indexed citations
13.
Palanski, Brad A., et al.. (2016). Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine. Journal of Biological Chemistry. 292(5). 2000–2008. 37 indexed citations
14.
Palanski, Brad A., et al.. (2015). An unprecedented dual antagonist and agonist of human Transglutaminase 2. Bioorganic & Medicinal Chemistry Letters. 25(21). 4922–4926. 9 indexed citations
15.
Alvarez-Sieiro, Patricia, M. Cruz Martín, Begoña Redruello, et al.. (2014). Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase. Applied Microbiology and Biotechnology. 98(15). 6689–6700. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026